Given the overlap in immunohistochemistry results for Ki-67, p53, and β-catenin, it would seem unlikely that these markers would provide much additional information to help distinguish fibroadenoma and phyllodes tumor. This evidence concerns the gene MKI67 and Fibroadenoma.